LDL Cholesterol Targets for Secondary Prevention After Myocardial Infarction
Primary LDL-C Target
- The American College of Cardiology recommends an LDL-C target of <55 mg/dL with at least a 50% reduction from baseline for patients with established coronary heart disease, who are classified as "very high risk" 1
- The European Society of Cardiology guidelines recommend LDL-C <1.8 mmol/L (~70 mg/dL) or a ≥50% LDL-C reduction when the target level cannot be reached for patients at very high cardiovascular disease risk 2
- Every 1.0 mmol/L reduction in LDL-C is associated with a 20-25% reduction in cardiovascular mortality and non-fatal myocardial infarction 2
Treatment Algorithm
- The American College of Cardiology recommends initiating high-intensity statin therapy immediately to achieve an LDL-C <70 mg/dL with at least a 50% reduction from baseline, and if this target is not met on maximal statin therapy, add ezetimibe to further lower LDL-C 1
- High-intensity statins include atorvastatin 40-80 mg daily or rosuvastatin 20-40 mg daily 1
- Statins should be initiated while the patient is still hospitalized after an acute coronary syndrome 2
- The goal is to achieve at least a 30-40% reduction in LDL-C levels, though ≥50% reduction is preferred 3, 4, 6, 7
Evidence Supporting the <70 mg/dL Target
- Achieving LDL-C <70 mg/dL is associated with the lowest risk of recurrent cardiovascular events in secondary prevention populations 2
Secondary Target: Non-HDL Cholesterol
- If triglycerides are ≥200 mg/dL, the non-HDL-C target should be <130 mg/dL (or <100 mg/dL as a more aggressive goal) 3, 4, 6, 7
- The 2025 guidelines recommend a secondary target of non-HDL-C <85 mg/dL (<2.2 mmol/L) for very high-risk patients 1
- Non-HDL-C is calculated as total cholesterol minus HDL-C 3, 9